These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15591841)

  • 1. A polymorphism of the gene encoding AMPD1: clinical impact and proposed mechanisms in congestive heart failure.
    Binkley PF; Auseon A; Cooke G
    Congest Heart Fail; 2004; 10(6):274-78; quiz 279-80. PubMed ID: 15591841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
    Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
    Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPD1 gene polymorphism and survival in patients with stable congestive heart failure.
    Palmer BR; Frampton CM; Richards AM; Cameron VA
    Am Heart J; 2007 May; 153(5):e13. PubMed ID: 17452134
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
    de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
    Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.
    de Groote P; Mouquet F; Dallongeville J; Lamblin N; Bauters C
    Am Heart J; 2007 May; 153(5):e15. PubMed ID: 17452135
    [No Abstract]   [Full Text] [Related]  

  • 6. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
    Safranow K; Suchy J; Jakubowska K; Olszewska M; Bińczak-Kuleta A; Kurzawski G; Rzeuski R; Czyżycka E; Łoniewska B; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
    J Appl Genet; 2011 Feb; 52(1):67-76. PubMed ID: 21108053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
    Loh E; Rebbeck TR; Mahoney PD; DeNofrio D; Swain JL; Holmes EW
    Circulation; 1999 Mar; 99(11):1422-5. PubMed ID: 10086964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
    Feldman AM; Wagner DR; McNamara DM
    Circulation; 1999 Mar; 99(11):1397-9. PubMed ID: 10086958
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
    Safranow K; Czyzycka E; Binczak-Kuleta A; Rzeuski R; Skowronek J; Wojtarowicz A; Jakubowska K; Olszewska M; Loniewska B; Kaliszczak R; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
    Scand J Clin Lab Invest; 2009; 69(1):102-12. PubMed ID: 18855224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
    Kolek MJ; Carlquist JF; Thaneemit-Chen S; Lazzeroni LC; Whiting BM; Horne BD; Muhlestein JB; Lavori P; Anderson JL
    J Card Fail; 2005 Dec; 11(9):677-83. PubMed ID: 16360962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
    Andreassi MG; Botto N; Laghi-Pasini F; Manfredi S; Ghelarducci B; Farneti A; Solinas M; Biagini A; Picano E
    Int J Cardiol; 2005 May; 101(2):191-5. PubMed ID: 15882662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
    Anderson JL; Habashi J; Carlquist JF; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Hart N
    J Am Coll Cardiol; 2000 Oct; 36(4):1248-52. PubMed ID: 11028479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
    Kalsi KK; Yuen AH; Johnson PH; Birks EJ; Yacoub MH; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):287-8. PubMed ID: 16021918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
    Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
    Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
    Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
    Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Leońska-Duniec A; Maculewicz E; Humińska-Lisowska K; Maciejewska-Skrendo A; Leźnicka K; Cięszczyk P; Sawczuk M; Trybek G; Wilk M; Lepionka W; Ficek K
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32429460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
    Yuen AH; Yacoub MH; Birks EJ; Kalsi KK; Johnson PH; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):275-7. PubMed ID: 16021915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of AMPD1 gene polymorphism on muscle activity in humans.
    Fedotovskaya ON; Danilova AA; Akhmetov II
    Bull Exp Biol Med; 2013 Feb; 154(4):489-91. PubMed ID: 23486588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait.
    Goodarzi MO; Taylor KD; Guo X; Quiñones MJ; Cui J; Li X; Hang T; Yang H; Holmes E; Hsueh WA; Olefsky J; Rotter JI
    Diabetes; 2005 Apr; 54(4):1222-7. PubMed ID: 15793265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment.
    Smolenski RT; Rybakowska I; Turyn J; Romaszko P; Zabielska M; Taegtmeyer A; Słomińska EM; Kaletha KK; Barton PJ
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):183-9. PubMed ID: 24431031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.